MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a biotechnology company specializing in the discovery, development, and commercialization of gene and cell therapies, biologics, and vaccines, has announced that its Chairman, CEO, and Co-Founder, Dr. Shankar Musunuri, will present at the esteemed NobleCon19 – Noble Capital Markets’ Nineteenth Annual Emerging Growth Equity Conference.
The conference, a significant event for investors and companies alike, will be held at Florida Atlantic University’s Executive Education Complex in Boca Raton, FL from December 3 – 5, 2023.
Dr. Musunuri is scheduled to present on Monday, December 4, 2023, in Presentation Room 1 at 2 p.m. ET. Following his presentation, there will be a moderated Q&A session allowing for greater interaction between company representatives and attendees.
Investors will also have the opportunity to meet with Ocugen’s management team during a breakout session at 2:30 p.m. ET at Breakout Table 1, located directly across from the presentation room. Here, Ocugen plans to conduct one-on-one meetings with registered investors to discuss the company’s business and clinical development strategy across its unique gene therapy, cell therapy, and vaccine platforms, as well as highlight recent corporate and pipeline-related achievements.
For those unable to attend in person, a webcast of the presentation will be made available the following day in the Events section of the Company’s website. The presentation will also be included in a complete catalog of presentations available at the Noble Capital Markets’ Conference website and on Channelchek—the investor portal created by Noble. The webcast will remain accessible on the Company’s website, the NobleCon website, and on Channelchek.com for 90 days following the event.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.